| publication name | Differential Expression of Autophagy-Related Marker (Beclin-1) in Relation to Clinicopathological Parameters in Different Breast Cancer Molecular Subtypes |
|---|---|
| Authors | RANIH Z. AMER; SHAIMAA M.N. EL-ZAMLY; HALA A. AGINA and MONA A.M. ABO EL-KHAIR |
| year | 2019 |
| keywords | Breast carcinoma – Molecular subtypes – Autophagy, Beclin-1. |
| journal | Med. J. Cairo Univ. |
| volume | 87 |
| issue | 2 |
| pages | 1209-1217 |
| publisher | Not Available |
| Local/International | Local |
| Paper Link | Not Available |
| Full paper | download |
| Supplementary materials | Not Available |
Abstract
Background: Beclin-1 plays a vital role in the vesicle nucleation in the process of autophagy and has an important role in development, tumorigenesis, and neurodegeneration. Aim of Study: Study the role of beclin-1 and correlate the degree of its expression with available clinic-pathological data in different molecular types of breast cancer. Material and Methods: Immunohistochemistry was performed to examine the expression of Beclin-1 different molecular subtypes of invasive ductal carcinoma and correlating it to clinicopathological parameter. Results: The expression of Beclin-1 was decreased in breast cancer in relation to normal tissue. High expression was significantly correlated with tumor grade, distant metastasis and stage. All the cases with high Beclin-1 expression were triple negative breast cancer cases. Conclusions: Triple negative breast cancer cases showed the highest tumor stage, grade, distant metastasis and beclin- 1 expression suggesting that the overexpression of Beclin 1 may by itself confer an aggressive biological course. It could be a therapeutic target.